Bullpup Scientific

About

Bullpup Scientific is developing the M/29 BullPup, a solution for IV access with a longer dwell time. The M/29 BullPup reduces restarts, needle sticks, and the number of insertion sites, as well as reducing vein damage. Its single, simple over-the-needle insertion lasts up to 29 days, with minimal training needed. The solution fills the current gap in effective IV access for the average hospitalized patient whose length of stay is expected to be longer than 2 to 3 days.

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Bullpup Scientific's primary product?

Bullpup Scientific's primary product is the M/29 BullPup, a midline IV catheter system designed for IV access with a longer dwell time, reducing restarts and needle sticks.

When was Bullpup Scientific founded?

Bullpup Scientific was founded in August 2015.

Where is Bullpup Scientific headquartered?

Bullpup Scientific is headquartered in Haifa, Israel, at David Elazar Street 10.

What problem does the M/29 BullPup solve?

The M/29 BullPup addresses the need for effective IV access for hospitalized patients with expected stays longer than 2 to 3 days, by providing a solution that lasts up to 29 days.

How many employees does Bullpup Scientific currently have?

Bullpup Scientific currently has 6 employees.

Who is a founder of Bullpup Scientific?

Ronen Radomski is a founder of Bullpup Scientific.

In which sector does Bullpup Scientific primarily operate?

Bullpup Scientific primarily operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.

What is the current stage of Bullpup Scientific's product, M/29 BullPup?

The M/29 BullPup product is currently released.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics

Target customers

Healthcare & Life SciencesHealthcareProvidersPatients

Business model

B2B

Bullpup Scientific — Full Company Profile (machine-readable)

Midline IV Catheter System

About

Facts

Name	Bullpup Scientific
Slug	bullpup-scientific
Type	Israeli Startup
Founded	2015
HQ city	Haifa
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object], [object Object]
Status	active
Current stage	Mature
Public stage	Mature
Total raised (USD)	0
Website	https://bullpupscientific.com/
Crunchbase ID	bullpup-scientific
Israeli Companies Registrar	515295905

Team (2)

Name	Role	LinkedIn
Shai Amishar
Ronen Radomski

Intelligence Q&A

What is Bullpup Scientific's primary product?

Bullpup Scientific's primary product is the M/29 BullPup, a midline IV catheter system designed for IV access with a longer dwell time, reducing restarts and needle sticks.

When was Bullpup Scientific founded?

Bullpup Scientific was founded in August 2015.

Where is Bullpup Scientific headquartered?

Bullpup Scientific is headquartered in Haifa, Israel, at David Elazar Street 10.

What problem does the M/29 BullPup solve?

The M/29 BullPup addresses the need for effective IV access for hospitalized patients with expected stays longer than 2 to 3 days, by providing a solution that lasts up to 29 days.

How many employees does Bullpup Scientific currently have?

Bullpup Scientific currently has 6 employees.

Who is a founder of Bullpup Scientific?

Ronen Radomski is a founder of Bullpup Scientific.

In which sector does Bullpup Scientific primarily operate?

Bullpup Scientific primarily operates in the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.

What is the current stage of Bullpup Scientific's product, M/29 BullPup?

The M/29 BullPup product is currently released.

About

Company Intelligence Q&A

Sectors & technology

Highlights

Tags